These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202 [TBL] [Abstract][Full Text] [Related]
6. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37. Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544 [TBL] [Abstract][Full Text] [Related]
7. Intracellular receptor for human host defense peptide LL-37 in monocytes. Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696 [TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenol epigallocatechin-3-gallate and cranberry proanthocyanidins act in synergy with cathelicidin (LL-37) to reduce the LPS-induced inflammatory response in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts. Lombardo Bedran TB; Palomari Spolidorio D; Grenier D Arch Oral Biol; 2015 Jun; 60(6):845-53. PubMed ID: 25791329 [TBL] [Abstract][Full Text] [Related]
9. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. Pistolic J; Cosseau C; Li Y; Yu JJ; Filewod NC; Gellatly S; Rehaume LM; Bowdish DM; Hancock RE J Innate Immun; 2009; 1(3):254-67. PubMed ID: 20375583 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs. Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860 [TBL] [Abstract][Full Text] [Related]
11. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910 [TBL] [Abstract][Full Text] [Related]
12. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS. Shaykhiev R; Sierigk J; Herr C; Krasteva G; Kummer W; Bals R FASEB J; 2010 Dec; 24(12):4756-66. PubMed ID: 20696857 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions. Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713 [TBL] [Abstract][Full Text] [Related]
14. The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Barlow PG; Beaumont PE; Cosseau C; Mackellar A; Wilkinson TS; Hancock RE; Haslett C; Govan JR; Simpson AJ; Davidson DJ Am J Respir Cell Mol Biol; 2010 Dec; 43(6):692-702. PubMed ID: 20097832 [TBL] [Abstract][Full Text] [Related]
15. Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa. McHugh BJ; Wang R; Li HN; Beaumont PE; Kells R; Stevens H; Young L; Rossi AG; Gray RD; Dorin JR; Gwyer Findlay EL; Brough D; Davidson DJ PLoS Pathog; 2019 Apr; 15(4):e1007694. PubMed ID: 30978238 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice. Iacob SA; Iacob DG Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632 [TBL] [Abstract][Full Text] [Related]